The Role of Photoprotection in Optimizing the Treatment of Atopic Dermatitis

Source : https://link.springer.com/article/10.1007/s13555-021-00495-y

Atopic dermatitis (AD) is a chronic inflammatory skin disease with an estimated prevalence of 10-15% in children and 2-10% in adults. Clinically, there is notable phenotypic variability driven by a...

The Wound Healing Peptide, AES16-2M, Ameliorates Atopic Dermatitis In Vivo

Source : https://www.mdpi.com/1420-3049/26/4/1168

Peptide materials have recently been considered for use in various industrial fields. Because of their efficacy, safety, and low cost, therapeutic peptides are studied for various diseases, including atopic dermatitis...

Reducing corticosteroid phobia in pharmacy staff and parents of children with atopic dermatitis

Source : https://link.springer.com/article/10.1007/s11096-021-01241-2

Background Besides physicians, pharmacy staff has an important role to inform patients on appropriate medication use. However, they might also experience corticophobia themselves, affecting patient counseling and subsequently patient's disease...

Staphylococcal Communities on Skin Are Associated with Atopic Dermatitis and Disease Severity

Source : https://www.mdpi.com/2076-2607/9/2/432

The skin microbiota of atopic dermatitis (AD) patients is characterized by increased Staphylococcus aureus colonization, which exacerbates disease symptoms and has been linked to reduced bacterial diversity. Skin bacterial communities...

Treatment with phosphodiester CpG-ODN ameliorates atopic dermatitis by enhancing TGF-β signaling - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/33612150/

Synthetic oligodeoxynucleotides (ODNs) containing unmethylated CpG phosphorothioate (PS CpG-ODN) are known to decrease IgE synthesis in Th2 allergy responses. Nonetheless, the therapeutic role of PS CpG-ODN is limited due to...